Latest News about QGEN
Recent news which mentions QGEN
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
From Benzinga
Qiagen, Inovio In Development Pact For VGX-3100 Companion Diagnostics
February 24, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
18 Stocks Moving In Tuesday's After-Hours Session
February 09, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 09, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
Earnings Scheduled For February 9, 2021
February 09, 2021
From Benzinga
The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment
February 02, 2021
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
November 19, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
From Benzinga
10 Stocks Moving In Wednesday's After-Hours Session
November 11, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
October 12, 2020
From Benzinga
The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street
October 08, 2020
From Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences
October 07, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
October 06, 2020
From Benzinga
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs
October 02, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For September 28, 2020
September 28, 2020
From Benzinga
44 Stocks Moving in Wednesday's Pre-Market Session
September 09, 2020
From Benzinga
Surge in megadeals points to M&A recovery as tech sector dominates
September 01, 2020
From MarketWatch
Benzinga's Top Upgrades, Downgrades For August 26, 2020
August 26, 2020
From Benzinga
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 24, 2020
August 24, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker, Inc.
Broker/Dealer, SEC Registered Investment Advisor, MSRB Registered Company | Member FINRA, SIPC
Accounts are carried by Pershing LLC, member FINRA, NYSE, SIPC, a wholly owned subsidiary of The Bank of New York Mellon Corporation (BNY Mellon)
Accounts carried by Raymond James & Associates, Inc., member New York Stock Exchange / SIPC